u25 Pill - gray oval, 9mm
Generic Name: brivaracetam
Pill with imprint u25 is Gray, Oval and has been identified as Briviact 25 mg. It is supplied by UCB, Inc.
Briviact is used in the treatment of Epilepsy; Seizures and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Briviact 25 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for u25
Briviact
- Generic Name
- brivaracetam
- Imprint
- u25
- Strength
- 25 mg
- Color
- Gray
- Size
- 9.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 5 - Some potential for abuse
- Labeler / Supplier
- UCB, Inc.
- National Drug Code (NDC)
- 50474-0470
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
betadex,
lactose anhydrous,
magnesium stearate,
magnesium silicate,
polyethylene glycol 3350,
titanium dioxide,
ferric oxide yellow,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "u25"
More about Briviact (brivaracetam)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (60)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Briviact drug information
- Briviact (Brivaracetam Intravenous) (Advanced Reading)
- Briviact (Brivaracetam Oral) (Advanced Reading)
- Briviact (Brivaracetam Injection)
- Briviact (Brivaracetam Oral Solution)
- Briviact (Brivaracetam Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
